Note: Ingredients listed on restricted chemical lists
EC/CAS
216-823-5/1675-54-3
Name of the chemical
2,2'-[(1-methylethylidene)bis(4,1-phenyleneoxymethylene)]bisoxirane
Concentration
50-100%
General Information
Revision date
2024-08-12
Product name
Epoxy Resin L
Emergency telephone
41 44 251 51 51
Icons in SDS
Company Information
company name
Suter Kunststoffe AG
e-mail address of the competent person responsible for the Safety Data Sheet
info@swiss-composite.ch
GHS Information
Signal word
Warning
Hazard Codes
Hazard statements (CLP)
H315, H317, H319, H411
Hazard statements
Code
Statements
H315
Causes skin irritation
Section 2
SECTION 2: Hazards identification
2.1 Classification of the substance or mixture
GB CLP Regulation Skin Irrit. 2; H315 Eye Irrit. 2; H319 Skin Sens. 1; H317 Aquatic Chronic 2; H411 Full text of hazard statements: see SECTION 16.
Hazard statements
see SECTION 16 H315 Causes skin irritation. H317 May cause an allergic skin reaction. H319 Causes serious eye irritation. H411 Toxic to aquatic life with long lasting effects.
2.2 Label elements
GB CLP Regulation
Hazardous Ingredients
2,2'-[(1-methylethylidene)bis(4,1-phenyleneoxymethylene)] bisoxirane Reaction mass of 2,2'-[methylenebis(4,1-phenyleneoxymethylene)]dioxirane and [2-({2-[4- (oxiran-2-ylmethoxy)benzyl]phenoxy}methyl)oxirane and [2,2'- [methylenebis(2,1-phenyleneoxymethylene)]dioxirane Reaction products of hexane-1,6-diol with 2-(chloromethyl) oxirane (1:2)
Signal word
Warning
Precautionary statements
P501 Entsorgung des Inhalts / des Behälters gemäß den örtlichen / regionalen /nationalen/ internationalen Vorschriften. P305+P351+P338 IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses, if present and easy to do. Continue rinsing. P333+P313 If skin irritation or rash occurs: Get medical advice/attention. P280 Wear protective gloves and eye protection/face protection. P273 Avoid release to the environment. P261 Avoid breathing dust/fume/gas/mist/vapours/spray.
2.3 Other hazards
The substances in the mixture do not meet the PBT/vPvB criteria according to REACH, annex XIII. The product does not contain any substances with endocrine-disrupting properties.